Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release May 13 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 3 pages · English and French

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release announcing the launch of Bemdac, a new drug for treating uncontrolled LDL-Cholesterol in India. This drug is intended for patients who do not achieve desired cholesterol levels despite maximum doses of statins. The launch addresses a significant healthcare need, as many patients struggle with high LDL-Cholesterol levels. Dr. Sharvil Patel emphasized the importance of Bemdac in improving patient quality of life through effective management of dyslipidemia.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases